The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Real-world experience (RWE) of safety and efficacy of 6-weekly pembrolizumab 400mg (pem6w) plus axitinib (axi) in patients (pts) with advanced renal cell carcinoma (aRCC).
 
Sonam Ansel
No Relationships to Disclose
 
Anirban Ray-Chaudhuri
No Relationships to Disclose
 
Robert J. Jones
Honoraria - Astellas Pharma; AstraZeneca; Bayer; Bristol-Myers Squibb; Clovis Oncology; Eisai; EUSA Pharma; Ipsen; Janssen; Merck Serono; MSD Oncology; Novartis; Pfizer; Pharmacyclics; Roche/Genentech; Sanofi; Seagen
Consulting or Advisory Role - Clovis Oncology
Research Funding - Astellas Pharma (Inst); AstraZeneca (Inst); Bayer (Inst); Clovis Oncology (Inst); Exelixis (Inst); Novartis (Inst); Pfizer (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Astellas Pharma; Bayer; Ipsen; Janssen; MSD
 
Mark Stares
No Relationships to Disclose
 
Tze-en Ding
No Relationships to Disclose
 
Stefan N. Symeonides
Consulting or Advisory Role - Bicycle Therapeutics (Inst); Bristol-Myers Squibb (Inst); Eisai (Inst); Ellipses Pharma (Inst); EUSA Pharma (Inst); MedAnnex (Inst); MSD (Inst); Pfizer/EMD Serono (Inst); Vaccitech (Inst)
Speakers' Bureau - Bristol-Myers Squibb (Inst); EUSA Pharma (Inst)
Research Funding - BiolineRx (Inst); BioNTech (Inst); Boston Pharmaceuticals (Inst); Merck Sharp & Dohme (Inst); Nouscom (Inst); Nucana (Inst); Sapience Therapeutics (Inst); Sierra Oncology (Inst); Verastem (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Ipsen
 
Christine Crearie
No Relationships to Disclose
 
Sarah Slater
No Relationships to Disclose
 
Maria Almudena Cascales Garcia
Honoraria - Pfizer
Travel, Accommodations, Expenses - Ipsen
 
Aravindhan Sundaramurthy
Stock and Other Ownership Interests - MSD Oncology (I)
Travel, Accommodations, Expenses - Bayer
 
Jahangeer Malik
Honoraria - EUSA Pharma; Pfizer; Pfizer
Consulting or Advisory Role - Eisai
 
Nicola Thomson
No Relationships to Disclose
 
Marie Pringle
No Relationships to Disclose
 
Gillian Barmack
Consulting or Advisory Role - Astellas Pharma; IPSEN
Speakers' Bureau - Astellas Pharma; Astellas Pharma
 
Balaji Venugopal
Honoraria - Bristol-Myers Squibb; Eisai; EUSA Pharma; Ipsen; Merck; MSD Oncology; Pfizer
Consulting or Advisory Role - Bristol-Myers Squibb; MSD Oncology; Pfizer/EMD Serono
Speakers' Bureau - Eisai; Janssen Oncology; MSD Oncology; Pfizer
Research Funding - Calithera Biosciences (Inst); Ipsen (Inst); MSD Oncology (Inst); Pfizer/EMD Serono (Inst)
Travel, Accommodations, Expenses - EUSA Pharma; Ipsen